COMMUNIQUÉS West-GlobeNewswire

Restrictive Covenants in Physician Employment Contracts Analyzed in the Journal of American Physicians and Surgeons (AAPS)
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- If an employment arrangement does not work out, physicians may have severely limited options for working elsewhere. Jeffrey Segal , M.D., J.D., explains issues to be [...]
The Association of American Physicians and Surgeons (AAPS) Helps Obtain a Unanimous Court Victory against Predatory Sports Gambling on Prediction Markets
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- On August 28, the U.S. Court of Appeals for the Ninth Circuit, which is the largest federal appellate court encompassing nine Western States, unanimously issued a [...]
UsAgainstAlzheimer's and CaringKind Collaborate to Offer Advocacy Opportunities for 100 Women of Impact
31/08/2026
Collaboration gives 100 Women of Impact the option to engage in federal Alzheimer’s and dementia advocacy through UsAgainstAlzheimer’s. WASHINGTON, Aug. 31, 2026 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s today announced [...]
Bloom Healthcare Expands Dallas-Fort Worth Presence with Acquisition of Christian Care House Calls
31/08/2026
Acquisition brings Christian Care House Calls providers into Bloom Healthcare and expands access to high-quality home-based primary care DENVER, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Bloom Healthcare , a passionate team of [...]
Physician Wins in Unlawful Search Case, according to the Journal of American Physicians and Surgeons (AAPS)
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- On his second trip to the U.S. Court of Appeals for the Fifth Circuit, Texas physician Courtney Morgan, M.D., won the right to his day in court over unlawful searches of [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
31/08/2026
Déclaration de transactions sur actions propres Paris, France (31 août 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 28 avril 2026, EssilorLuxottica déclare que du 25 août 2026 au 27 [...]
EssilorLuxottica: Disclosure of transactions in own shares
31/08/2026
Disclosure of transactions in own shares Paris, France (August 31, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 35 - 2026
31/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 24 août au 28 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2026
31/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 24th August to 28th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
Physicians Need to Fight for the Cause of America, Writes President of the Association of American Physicians and Surgeons (AAPS)
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- On the 250 th anniversary of our Declaration of Independence, the need for physicians to fight for the Cause of America is increasingly urgent, writes George L. Smith , [...]
Physician Health Programs Need Reform, according to the Journal of American Physicians and Surgeons
31/08/2026
TUCSON, Ariz., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Although Physicians Health Programs (PHPs) are purportedly for helping impaired physicians recover and return to practice, the only thing that may be missing from the [...]
"Traverser la séparation" Launches a Specialized Psychotherapy Program for Adults Facing a Painful Breakup
31/08/2026
Confronting a form of suffering that is still too often downplayed, the practice founded by psychotherapist Gérald Bovet offers a structured eight-week framework — online and in person — combining a psychoanalytic [...]
Teladoc Health Appoints Michael Grasher as Chief Financial Officer
31/08/2026
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC [...]
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
31/08/2026
- IMPACT, a multicenter pilot study of Alpha DaRT ® for newly diagnosed unresectable pancreatic cancer, expanded enrollment three times over the course of the study, from an original enrollment of 12 patients to a total [...]
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
31/08/2026
TEL AVIV, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for immune-fibrotic diseases with high [...]
ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib
31/08/2026
Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in the Phase Ib FRIDA trial in patients with FLT3-mutated relapsed/refractory (R/R) AML FRIDA data [...]
Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation
31/08/2026
Company aims to deliver the first FDA-approved recombinant botulinum neurotoxin type A (rBoNT/A) Phase II study in moderate-to-severe glabellar lines completed; topline data expected in Q3 2026 Dustin Sjuts, former [...]
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference
31/08/2026
ALISO VIEJO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX ® (onabotulinumtoxinA) [...]
BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
31/08/2026
Last Patient Last On-Site Visit Completed with Topline Data Release Targeted September 2026 CARSON CITY, Nev., Aug. 31, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage [...]

Pages